scispace - formally typeset
I

Ivan Zanoni

Researcher at Boston Children's Hospital

Publications -  112
Citations -  6957

Ivan Zanoni is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Innate immune system & Immune system. The author has an hindex of 36, co-authored 106 publications receiving 5323 citations. Previous affiliations of Ivan Zanoni include Harvard University & University of Milan.

Papers
More filters
Journal ArticleDOI

Innate immune pattern recognition: a cell biological perspective.

TL;DR: This review highlights aspects of cell biology in pattern-recognition receptor signaling by focusing on signals that originate from the cell surface, from endosomal compartments, and from within the cytosol.
Journal ArticleDOI

CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4

TL;DR: It is reported that the plasma membrane localized Pattern Recognition Receptor (PRR) CD14 is required for the microbe-induced endocytosis of TLR4, and this innate immune trafficking cascade illustrates how pathogen detection systems operate to induce both membrane transport and signal transduction.
Journal ArticleDOI

An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells

TL;DR: It is reported that encounters with microbial products and self-encoded oxidized phospholipids (oxPAPC) induce an enhanced DC activation state, which is called “hyperactive” and induce potent adaptive immune responses and are elicited by caspase-11, an enzyme that binds oxP APC and bacterial lipopolysaccharide (LPS).
Journal ArticleDOI

CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation

TL;DR: It is shown that mouse dendritic cell stimulation with lipopolysaccharide (LPS) induces Src-family kinase and phospholipase Cγ2 activation, influx of extracellular Ca2+ and calcineurin-dependent nuclear NFAT translocation, and LPS-induced NFAT activation via CD14 is necessary to cause the apoptotic death of terminally differentiateddendritic cells.
Journal ArticleDOI

Type III interferons disrupt the lung epithelial barrier upon viral recognition.

TL;DR: A strong rationale is provided for rethinking the pathophysiological role of IFN-λ and its possible use in clinical practice against endemic viruses, such as influenza virus as well as the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.